POSTER SESSION III Tuesday, March 20, 2012   —  9:30 AM - 12:00 Noon CC Exhibit Hall B3 & C Click on the blue numbers in parentheses to display abstracts. Click the button next to any title to add to Itinerary Planner... HEMATOPATHOLOGY Poster# Title and Authors Itinerary Planner 204 LMO2 (LIM Domain Only 2, Rhombotin-Like 1) Is Expressed in a Subset of Acute Myeloid Leukemia Patients and Correlates with Normal Cytogenetic Status (1510) JL Patel, S-J Haggstrom, P Pournazari, F Kosari, Y Natkunam, A Mansoor - University of Calgary and Calgary Laboratory Services, Calgary, AB, Canada; Stanford University School of Medicine, Stanford, CA Add 205 HIF1a Expression Is Associated with NPM1 Mutation, but Not IDH1 or IDH2 Mutations in Acute Myeloid Leukemia with Normal Karyotype (1431) S Hu, V Ruvolo, H Lu, HM Kantarjian, D Wheeler, DM Muzny, LJ Medeiros, C Bueso-Ramos, M Konopleva, M Andreeff, S Konoplev - University of Texas MD Anderson Cancer Center, Houston; Baylor College of Medicine, Houston Add 206 Endoglin (CD105) Is Strongly Overexpressed in AML with t(15;17)/PML-RARA and Is Significantly Associated with IDH2 Mutation, but Is Not Expressed in Bone Marrow Endothelial Cells (1373) Z Chakhachiro, z Zuo, H Kantarjian, J Cortes, K AlAyed, M Nguyen, S Vadhan-Raj, J Medeiros, C Bueso-Ramos - MD Anderson Cancer Center, Houston, TX Add 207 The Prevalence of CD56 Expression by Flow Cytometry in Acute Promyelocytic Leukemia Patients Treated with All- Trans Retinoic Acid and Anthracycline Drug Combinations (1506) H Olteanu, AM Harrington, SH Kroft, NJ Karandikar, FF Fuda - Medical College of Wisconsin, Milwaukee, WI; UT Southwestern Medical Center, Dallas, TX Add 208 B-Cell Expression and B-Cell Gene Rearrangements in AML with t(8;21)(q22;q22) (1447) RC Johnson, L Ma, DA Arber, TI George - Stanford University, Stanford, CA Add 209 Characterization of Bone Marrow Mast Cells in RUNX1- RUNX1T1 Acute Myeloid Leukemia (1521) ST Pullarkat, VA Pullarkat, A Lagoo, W Chen, V Bedell, R Brynes, S Yea, Q Huang, Y Kim - UCLA, David Geffen School of Medicine, Los Angeles, CA; USC -Keck School of Medicine, Los Angeles, CA; Duke University Medical Center, Durham, NC; City of Hope National Medical Center, Duarte, CA Add 210 Acute Myeloid Leukemia Associated with Isolated Del(6q) Demonstrates Unique Clinical, Morphological and Cytogenetic Characteristics (1425) D Hoehn, P Lin, R Muddasani, D Ng, KH Young, G Lu - The University of Texas M.D. Anderson Cancer Center, Houston, TX Add 211 Myeloid Neoplasia with t(3;8)(q26;q24): Report of Four Cases and Review of the English Literature (1598) X Xu, M Su, NB Levy, P Kaur, R Garcia, A Mohtashamian, HE Broome, ML Dell´Aquila, H-Y Wang - Univ. of California San Diego, La Jolla, CA; Univ. of Texas Southwestern Medical Center, Dallas, TX; Dartmonth- Hitchcook Medical Center, Lebanon, NH; Naval Medical Center San Diego, San Diego, CA Add 212 Acquired Trisomy 21 as a Sole Chromosomal Abnormality Is Associated with a Heterogeneous Group of Myeloid Neoplasms and Variable Disease Outcome (1381) SS Chen, CC Yin, SN Konoplev, KH Young, R Muddasani, LJ Medeiros, G Lu - University of Texas MD Anderson Cancer Center, Houston, TX Add 213 Myeloid Neoplasms with inv(3)(q21q26.2)/t(3;3)(q21;q26.2) Are Aggressive Neoplasms Irrespective of Blast Count (1585) DW Warden, HJ Rogers, J Cook, ED Hsi - Cleveland Clinic, Cleveland, OH Add 214 Acute Myeloid Leukemia with Translocations Involving 4q12/ PDGFRA: Frequent Involvement of ETV6 (1450) R Kanagal-Shamanna, CC Yin, R Muddasani, R Luthra, J Cortes, Z Zuo, SS Chen, D Hoehn, LV Abruzzo, RN Miranda, LJ Medeiros, G Lu - UT MD Anderson Cancer Center, Houston Add 215 Clinical and Biological Characteristics of Phenotypically Poorly Differentiated Acute Leukemias (1530) N Rodic, A Duffield, CD Gocke, KH Burns, MJ Borowitz, M Vuica-Ross - Johns Hopkins Medical Institute, Baltimore, MD Add 216 Acute Myeloid Leukemia with Minimal Differentiation: TdT Expression Is Associated with Better Overall Survival Following Stem Cell Transplantation (1511) KP Patel, FA Khokhar, T Muzzafar, MJ You, F Ravandi, C Bueso-Ramos, LJ Medeiros - The University of Texas M.D. Anderson Cancer Center, Houston, TX Add 217 Immunophenotypic Aberrancies in the Maturing Myeloid and Monocytic Compartment in Acute Myeloid Leukemia by Flow Cytometry (1512) y Pei, J Schallheim, G Fan - Oregon Health & Science University, Portland Add 218 Flow Cytometric Blast Immunophenotype in Acute Myeloid Leukemias Arising from Non-Acute Myeloid Disorders (1581) J Vaughan, H Olteanu, SH Kroft, AM Harrington - Medical College of Wisconsin, Milwaukee, WI Add 219 Blast Immunophenotypes by Flow Cytometry in Acute Myeloid Leukemia with Myelodysplasia-Related Changes (1580) J Vaughan, H Olteanu, SH Kroft, AM Harrington - Medical College of Wisconsin, Milwaukee, WI Add 220 WT1 RNA Expression in Different Cell Lineages in Normal and Leukemic Bone Marrow (1356) DC Ang, F Yang, C Qu, G Lanier, G Fan, R Press - Oregon Health and Science University, Portland, OR Add 221 Plasmacytoid Dendritic Cell Marker CD123 Alone Does Not Have Prognostic Value in Acute Myeloid Leukemia (AML) (1605) D Zhang, L Blick, M Davis, W Cui, MT Cunningham - University of Kansas Medical Center, Kansas City, KS; University of Massachusetts Medical School, Worcester, MA Add 222 Prognostic Factors in Unfavourable-Risk Acute Myeloid Leukemia in the Absence of Monosomal Karyotype (1380) M Chen, J Brandwein, KJ Craddock, H Chang - University Health Network, University of Toronto, Toronto, Canada Add 223 Post Stem Cell Transplantation Monitoring in Acute Myeloid Leukemia by Markers of Minimal Residual Disease and Engraftment (1453) AS Kim, MK Kressin, CA Mosse, A Seegmiller - Vanderbilt University Medical Center, Nashville, TN Add 224 Leukemia-Associated Aberrant Immunophenotype (LAIP) in Patients with Acute Myeloid Leukemia (AML): Changes at Refractory Disease or First Relapse and Clinicopathological Findings (1388) W Cui, D Zhang, M Cunningham, L Tilzer - The University of Kansas Medical Center, Kansas City, KS Add 225 Bone Marrow Cellularity during Induction Is Highly Predictive of Complete Remission in De Novo AML but Not in Secondary/Therapy-Related AML (1610) G Zheng, AE DeZern, KW Pratz, JE Karp, CD Gocke - Johns Hopkins University School of Medicine, Baltimore, MD Add 226 Re-Evaluation of Risk Factors for Relapse in APL Patients Treated with All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (ATO) Frontline Chemotherapy (1612) Y Zhou, R Luthra, F Ravandi, H Kantarjian, JL Jorgensen, C Bueso-Ramos, LJ Medeiros, S Konoplev - Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX Add 227 A Simple Approach to Flow Cytometric Assessment of Myeloid Dysmaturation (1445) D Jevremovic, MT Timm, CA Hanson, WG Morice, PL Nguyen - Mayo Clinic, Rochester, MN Add 228 Flow Cytometry Immunophenotyping (FCIP) of Bone Marrow Blasts in Myeloid Neoplasms: Distinction from Normal Does Not Require Increased Blasts (1502) PL Nguyen, MM Timm, WG Morice, CA Hanson, D Jevremovic - Mayo Clinic, Rochester, MN Add 229 Application of Flow Cytometry, Fluorescent In- Situ Hybridization and Cytogenetics in Diagnosis of Myelodysplastic Syndrome (1606) P Zhang, D Harris, R Fulks, ST Zhang, A Cinco - St. Francis Hospital, Thomas Healthcare System, Charleston, WV Add 230 Limited Diagnostic Utility of MDS FISH Testing in Myeloid Neoplasms at Diagnosis and Follow-Up (1540) AC Seegmiller, M Kressin, AS Kim, CA Mosse - Vanderbilt University Medical Center, Nashville, TN; Tennessee Valley Healthcare System, Nashville, TN Add 231 Myelodysplastic Syndrome with Complex Cytogenetics Abnormalities and CD34+ Megakaryocytes (1378) SS Chekol, Q Chen, NM Nanaji - University of Maryland Medical Center, Baltimore, MD Add 232 CD34 Staining in Megakaryocytes Is Not Specific for Myeloid Malignancies and Has Minimal Diagnostic Value (1592) DS West, CA Hanson, ED McPhail, JD Hoyer - Mayo Clinic, Rochester, MN Add 233 Significance of P53 Immunostaining in the Diagnosis of Myelodysplastic Syndromes (1494) Z Mohammad Taheri, P Pournazari, I Auer, A Mansoor, J Luider, M Torbatian, M-T Shabani-Rad - University of Calgary/Calgary Laboratory Services, Calgary, Canada; National Research Institute of Tuberculosis and Lung Disease, Tehran, Islamic Republic of Iran Add 234 G-CSF-R (CD114) Expression Patterns in Normal and Malignant Hematopoiesis: Recurring Phenotypic Abnormalities in Myelodysplasia and Chronic Myelogenous Leukemia (1420) VS Hanumanthu, SJ Pirruccello - UNMC, Omaha, NE Add 235 Utility of CD117 Immunohistochemistry in Evaluation of Myelodysplastic Syndrome (1597) X Wu, J Zhou, S Zhang, M Nassiri, M Czader - Indiana University, Indianapolis, IN Add 236 Decreased Expression of Myelopoiesis Determining Factor PU.1 in Myelodysplastic Syndrome (MDS) (1469) DG Leino, DP Arps, JX Cheng - University of Michigan, Ann Arbor, MI Add 237 Increased Bone Marrow Mast Cells, Enumerated by Multiparameter Flow Cytometry, Are Associated with Myelodysplastic Syndromes (1371) FJ Castro-Silva, FS Fuda, NJ Karandikar - University of Texas Southwestern, Dallas, TX Add 238 Paraneoplastic Skin Findings in Patients with Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia (1513) D Peker, L Moscinski, R Mathew, L Zhang - H. Lee Moffitt Cancer Center, Tampa, FL Add 239 Bone Marrow Histopathology in 8 Patients with Myeloid Neoplasms and PRDM16 Translocations: Analysis Reveals Recurring Dysplastic Features (1390) LN Dao, RA Knudson, RP Ketterling, WR Sukov - Mayo Clinic, Rochester, MN Add 240 Fli-1 Expression Is Increased in Erythroblasts in MDS with Del(5q) and Correlates with Response to Lenalidomide (1366) DF Boyer, E Attar, RP Hasserjian - Massachusetts General Hospital, Boston Add 241 Next Generation Sequencing Leads to the Discovery of Novel Associations of miRNA with Myelodysplastic Syndromes (1413) JM Gonzalez Berjon, K Alvarez, E Hudspeth, J Wen, FA Monzon Bordonaba, RJ Olsen, Y Zu, X Zhou, J Chang - The Methodist Hospital/Weil Medical College of Cornell University, Houston, TX; The Methodist Hospital, Houston, TX; Florida Hospital, Orlando, FL; Baylor College of Medicine, Houston, TX Add